Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron and COPD Exercise Trial
2016-000829-39Phase 2Unknown
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Ferinject (ferric carboxymaltose) with Placebo (saline for injection) (2 arms). Primary endpoint: Change in endurance cycle ergometer time. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2016-000829-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000829-39.